News: Dexa Medica

The government primarily focuses on developing phytopharmaceuticals to create a system of health resilience and domestic pharmaceutical self-reliance. Launching the Phytopharmaca Formulary and promoting its usage in medical institutions are examples of the government's commitment to fostering the use of phytopharmaceuticals. The Director General of Pharmaceuticals and Medical Devices at…

With more than 28000 plant species and 2,848 medicinal plants, Indonesia has the second-highest biodiversity in the world. Its natural resources hold tremendous promise for developing phytopharmaceuticals and herbal medicines, including Indonesia Indigenous Modern Medicine (IIMM). Penny K. Lukito, head of the Food and Drug Supervisory Agency (BPOM), stated that…

The Indonesian government continues to encourage the resilience and independence of the healthcare industry, as imports dominate 90% of its domestic pharmaceutical raw materials and health spending. In addition, 88% of medical device transactions through electronic catalogs (e-catalogs) are imported products. Meanwhile, research and development funds are only about 0.2%…

The Covid-19 epidemic has given Indonesia's pharmaceutical sector a fresh start. In stark contrast to the average 5–10% growth rate, the pharmaceutical sector shrank by -1.6 percent. Meanwhile, a supply shock made it challenging for the nation to get medical raw materials (BBO) since imports met 90% of BBO requirements.…

STIMUNO has served as Indonesia's first phytopharmaceutical immunomodulator for over two decades. It also has won several honors since its initial release in 1999. For the 12th year in a row, STIMUNO syrup won the Top Brand For Kids Awards in the Children's Immune System Vitamins category. Marketing Magazine and…

According to the Indonesia Nutrition Status Survey (SSGI), in 2021, the prevalence of stunting in Indonesia will be 24.4 percent, a 6.4 percent decrease from 30.8 percent in 2018. To meet the goal of reducing stunting prevalence to 14 percent by 2024, the Population Agency and the National Family Planning…

The economic crisis that hit Sri Lanka caused a lack of supplies of medicines in the country and encouraged the concern of pharmaceutical companies in Indonesia to donate medicines and medical devices, including Dexa Group. The World Health Organization authorities submitted the request to the Indonesian government through the Indonesian…

As the world's fifth-largest elderly population, Indonesia offers a substantial market potential for health goods and services for the elderly. As a result, to enhance the quality of life of the elderly in Indonesia, innovation and research in geriatrics, particularly by native researchers, must be supported. This statement was conveyed…

Dexa Group is one of the pharmaceutical companies that take part in Business Matching activities organized by the Ministry of Industry to maximize the purchase of domestic products. The event, which took place on the 22nd until 24th of March 2022 in Nusa Dua, Bali, continued the Bangga Buatan Indonesia…

The Indonesian Doctors Association inaugurated the erection of a monument named "Pengabdian Dokter Indonesia" to remember the services of doctors who died to preserve the lives of Indonesians while dealing with COVID-19. Dexa Group took part in the establishment and inauguration of the monument, which took place on Thursday, March…